Rheumatoid arthritis
Conditions
Interventions
Sponsors
The Second Affiliated Hospital of the Army Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients admitted to the Department of Dermatology, Rheumatology and Immunology, gender is not limited, age >=18 years 2. Patients who meet the diagnostic criteria for rheumatoid arthritis from the American College of Rheumatology (ACR) or the European League Against Rheumatism (EULAR). 3. Methotrexate has been taken for more than 3 months 4. Patients voluntarily participate in this study and sign the informed consent form
Exclusion criteria
Exclusion criteria: 1. Concomitant use of biologically modifying antirheumatic drugs (DMARDs) or targeted synthetic disease-modifying antirheumatic drugs 2. Concomitant use of glucocorticoid prednisone (or equivalent other hormones) greater than 10mg 3. The patient's case data is incomplete
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease activity score (DAS);Methotrexate plasma concentration; | — |
Countries
China
Contacts
Public ContactFei Ye
The Second Affiliated Hospital of the Army Medical University
Outcome results
None listed